Cancer Genomics Consortium
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2013 | 197,282 | 150,891 | 46,391 | 12.9 | — |
| 2014 | 127,715 | 124,525 | 3,190 | 16.0 | — |
| 2015 | 170,088 | 88,227 | 81,861 | 33.7 | — |
| 2016 | 147,174 | 154,645 | −7,471 | 18.7 | — |
| 2017 | 207,161 | 194,277 | 12,884 | 15.6 | 0% |
| 2018 | 288,811 | 258,884 | 29,927 | 13.1 | 0% |
| 2019 | 327,435 | 308,911 | 18,524 | 11.7 | 0% |
| 2020 | 155,534 | 145,205 | 10,329 | 25.8 | 0% |
| 2021 | 289,070 | 180,642 | 108,428 | 27.9 | 0% |
| 2022 | 471,897 | 380,318 | 91,579 | 16.2 | 0% |
| 2023 | 441,040 | 446,547 | −5,507 | 13.6 | 0% |
In its most recent public year (2023), this organization spent $5,507 more than it brought in. Its reserves stood at about 13.6 months of spending. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Cancer Genomics Consortium's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works